Clinical trial

Respiratory Effects of E-Cigarettes in Obese Youth

Active, not recruiting · Not applicable · 1 countries · Registry ID NCT05869318

Active, not recruitingNot applicableInterventional

What this study is about

To determine vaping behaviors and respiratory function in obese and nonobese youth e-cigarette users.

A promising-looking record is not the same as confirmed eligibility. The study team must review the full criteria and current recruitment status.

Basic eligibility

Age21 Years to 25 Years
SexAll
Healthy volunteersNot accepted
ConditionE-Cig Use

Full registry criteria

Inclusion Criteria: * a current e-cigarette user (≥1 vaping bout daily) for at least the past 3 months, * 21-25 years old, * willing to abstain from all tobacco and nicotine for at least 12 hours prior to lab sessions, * willing to complete five lab visits lasting up to 4 hours each, * able to read and speak English, * willing to provide informed consent. Exclusion Criteria: * self-reported diagnosis of lung disease including asthma or cystic fibrosis * history of cardiac event or distress within the past 3 months * history of metabolic disease including thyroid disease or diabetes * history of orthopedic or neuromuscular problems that preclude exercise * currently pregnant (determined using urine pregnancy test), planning to become pregnant, delivered a child in the past 6 weeks even if not breastfeeding, or currently breastfeeding * use of other tobacco products \>10 days in the past month * current marijuana use \>10 times per month * currently engaging in a vaping cessation attempt * ) competitive athlete or individual currently engaged in an exercise training program involving 420min or more (moderate intensity aerobic activity) or 210 min or more (vigorous intensity aerobic activity) per week with the goal of participating in a competitive event or marathon, triathlon, etc. Participants who are engaged in usual physical activity (e.g., walking dog, biking to work, etc.) but not engaged in a "structured exercise training program" will not be excluded. * plans to leave the Columbus or central Ohio region within the next year.

Treatments and study arms

ECIG own

Other

Participants will vape using their own ecig device

ECIG Vuse

Other

Participants will vape a VUSE e-cigarette (GOLD 5%)

Primary outcomes

Forced expiratory volume in 1 secondChange from 0 to 35 minutes

Spirometry will be completed before and after a 35 min vaping session

Functional residual capacityChange from 0 to 35 minutes

Plethymosgraphy will be completed before and after a 35 min vaping session

Diffusion capacityChange from 0 to 35 minutes

DLCO will be completed before and after a 35 min vaping session

Airway resistanceChange from 0 to 35 minutes

Plethymosgraphy to measure airway resistance (Raw) will be completed before and after a 35 min vaping session

Puff count35 minutes

E-cig puff topography data collection for abuse liability

Average Puff duration35 minutes

E-cig puff topography data collection for abuse liability

Average Puff volume35 minutes

E-cig puff topography data collection for abuse liability

Study locations

1 locations were listed when this page was built. The first 40 are shown.

The Ohio State University🇺🇸 Columbus, Ohio, United States